Company intelligence / Profile preview

Eugene Labs

Richmond, Victoria, Australiaeugenelabs.com ↗

Ownership: Private
Employees: ~61
Development stage: Commercial

Overview

Eugene Labs offers clinically validated at-home genetic tests and digital counseling services focused on reproductive planning, cancer predisposition, and cardiovascular risk. Their non-invasive saliva-based tests are supported by a team of clinical geneticists and counselors. The company is active in Australia and New Zealand with over 25,000 users served. No interventional therapeutics or drug development; the focus is on preventive genomics.

Therapeutic areas: OncologyCardiovascularWomen's Health
Modalities: Diagnostic test (genetic testing)Digital health service
Industry: Molecular Diagnostics

Partnerships

Bupa Ventures (strategic investment partnership)

Beyond the preview

Go deeper on Eugene Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eugene Labs.

Explore the full profile